None
Quote | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Last: | $2.075 |
---|---|
Change Percent: | 1.72% |
Open: | $2.07 |
Close: | $2.04 |
High: | $2.1 |
Low: | $2.04 |
Volume: | 219,412 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
2024-03-22 09:05:08 ET More on Checkpoint Therapeutics Checkpoint Therapeutics to raise ~$14M Seeking Alpha’s Quant Rating on Checkpoint Therapeutics Historical earnings data for Checkpoint Therapeutics Financial information for Checkpoint Therapeutics...
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2023, and recent corporate highlights....
Message Board Posts | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Subject | By | Source | When |
---|---|---|---|
$CKPT............................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g | glenn1919 | investorshub | 04/29/2023 12:50:02 PM |
$CKPT.......................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id | glenn1919 | investorshub | 04/22/2023 12:17:50 PM |
$CKPT.....................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id=p | glenn1919 | investorshub | 04/15/2023 7:26:28 PM |
This stock sure is volatile!! | vein | investorshub | 01/18/2023 2:54:08 PM |
Yeah , especially with the rise in stock price | vein | investorshub | 01/14/2023 6:05:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2023, and recent corporate highlights....
WALTHAM, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...
WALTHAM, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the appointment of Amit Sharma, M.D., FACP, FASN, FNKF, to its Board as an independent, non-e...